Zobrazeno 1 - 10
of 74
pro vyhledávání: '"CGM (continuous glucose monitoring)"'
Autor:
Marta Bassi, Daniele Franzone, Francesca Dufour, Giordano Spacco, Federico Cresta, Giuseppe d’Annunzio, Giacomo Tantari, Maria Grazia Calevo, Carlo Castellani, Nicola Minuto, Rosaria Casciaro
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Background and aimsCystic fibrosis related diabetes (CFRD) is correlated with worsening of nutritional status and greater deterioration of lung function. The role of new technologies for the treatment of CFRD is little explored. The aim of the study
Externí odkaz:
https://doaj.org/article/59ba0506af3243d3afb8590729ca3939
Publikováno v:
Frontiers in Transplantation, Vol 2 (2024)
BackgroundPost-Transplant Diabetes Mellitus (PTDM) affects 20%–40% of lung transplant recipients within five years, impacting rejection, infection, cardiovascular events, and mortality. Continuous glucose monitoring (CGM) is used in diabetes but no
Externí odkaz:
https://doaj.org/article/cdbf55e81bb94c8e89dd4b816939c598
Autor:
Marta Bassi, Marina Francesca Strati, Valentina Andreottola, Maria Grazia Calevo, Giuseppe d’Annunzio, Mohamad Maghnie, Nicola Minuto
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
ObjectiveTandem Control-IQ is an advanced hybrid closed loop (AHCL) system with a Sleep Activity Mode to intensify glycemic control overnight. The aim of the study is to evaluate the effectiveness of using Sleep Mode or not among Tandem Control-IQ us
Externí odkaz:
https://doaj.org/article/02dd5518f4f6438abf17a4e7af0f8d2e
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
The COVID-19 pandemic has stimulated a rapid shift towards telemedicine, which has had tremendous repercussions on all domains of the healthcare ecosystem. The effects of the transition to telemedicine on post-graduate medical education and on patien
Externí odkaz:
https://doaj.org/article/5b3d6a3fe20745aab8b49427aeb77845
Autor:
N. A. Chernikova, L. L. Kamynina, A. S. Ametov, D. A. Sychev, E. A. Grishina, K. A. Ryzhikova
Publikováno v:
Терапевтический архив, Vol 92, Iss 10, Pp 54-62 (2020)
Aim.To investigate the link between the hypoglycemia (registrated accurately by the professional Continuous Glucose Monitoring CGM; severe hypoglycemia at home) and the hetero-/homozygote carriage of single nucleotide polymorphisms (SNP) of cytochrom
Externí odkaz:
https://doaj.org/article/06dad1e45df24ff5ba09f393f973032b
Autor:
Marta Bassi, Marsida Teliti, Marilea Lezzi, Arianna Iosca, Marina Francesca Strati, Luca Carmisciano, Giuseppe d’Annunzio, Nicola Minuto, Davide Maggi
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2022)
Tandem Control-IQ and Minimed 780G represent the most Advanced Hybrid Closed Loop (AHCL) systems currently available in pediatric and adult subjects with Type 1 Diabetes (T1D). We retrospectively compared clinical and continuous glucose monitoring da
Externí odkaz:
https://doaj.org/article/1acd879f6c994b5f995cc48248945cc3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Johan H. Jendle, Michael C. Riddell
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2019)
Externí odkaz:
https://doaj.org/article/385f1c7220374bd284ae3b8910c9c627
Publikováno v:
AACE Clinical Case Reports, Vol 7, Iss 5, Pp 307-309 (2021)
AACE Clinical Case Reports
AACE Clinical Case Reports
Objective Insulin antibody (IA)-mediated insulin resistance (IR) is a rare condition for which immunosuppressive regimens have been described. However, these raise the risk of infection, and the drugs may not be effectively metabolized in patients wi
Autor:
Darío Parra, Oscar Muñoz, Diana Henao, Marisol Vergara Pinilla, Martín Rondón, Alfonso Kerguelen, Ana María Gómez
Publikováno v:
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Diabetes & Metabolic Syndrome
Diabetes & Metabolic Syndrome
Background and aims In Colombia, the government established mandatory isolation after the first case of COVID-19 was reported. As a diabetes care center specialized in technology, we developed a virtual training program for patients with type 1 diabe